Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. KKR
7. NTNX
8. P
9. HPQ
10. A

Go back to Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications
(NASDAQ: ARQT) Delayed: 25.14 --0 (-0%)
Previous Close $25.14    52 Week High $ 
Open $25.14    52 Week Low $ 
Day High $25.14    P/E N/A 
Day Low $25.14    EPS $ 
Volume 4,703